The impact of 68Ga-PSMA PET/CT on decision-making and disease management has been reviewed, and it is clear that 68Ga-PSMA PET/CT has significantly impacted clinical decision-making, especially for the high-risk PCa cohort [13]. Here, FOLH1 is linked to posterior cortical atrophy.